Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression.
Tanabe
K
K
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Tokumoto
T
T
Ishikawa
N
N
Shimizu
T
T
Okuda
H
H
Ito
S
S
Shimmura
H
H
Inui
M
M
Harano
M
M
Manu
M
M
Koga
S
S
Ohtsubo
S
S
Suzuki
K
K
Shiroyanagi
Y
Y
Goya
N
N
Nakazawa
H
H
Yagisawa
T
T
Nakajima
I
I
Fuchinoue
S
S
Toma
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007223:Infant; D007564:Japan; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016559:Tacrolimus; D008775:Methylprednisolone